Skip to main content
Shinya Yamanaka, MD, PhD portrait image
Shinya Yamanaka, MD, PhD portrait image

In 2006, Shinya Yamanaka discovered that adult somatic cells can be reprogrammed into an embryonic-like pluripotent state by delivering transcription factors. These reprogrammed cells, known as induced pluripotent stem (iPS) cells, have the potential to develop into every cell type in the body and are invaluable tools for disease modeling, drug screening, and cell therapy.

iPS cells also provide an unprecedented opportunity for discovery in life science, and in Yamanaka’s lab today, researchers continue to use them to investigate the mechanisms for cell fate determination, the reprogramming process, and pluripotency.

Disease Areas

  • Genetic Diseases
  • Intractable and Rare Diseases

Areas of Expertise

Shinya Yamanaka

Lab Focus

  • Investigating the molecular mechanisms that underlie cellular reprogramming by defined factors.
  • Determining the mechanisms of post-transcriptional regulation and how they influence pluripotency and cell fate.
  • Establishing an innovative approach to study diseases by in-depth analysis of pluripotent stem cells.

Research Impact

Work from Yamanaka’s lab has demonstrated that a few transcription factors in combination can reprogram cell fate from somatic lineages back to a pluripotent state. This groundbreaking work established the field of iPS cell technology, and hundreds of scientists are now trying to bring the technology to patients. Continuing efforts in Yamanaka’s lab to elucidate the mechanisms underlying pluripotency and reprogramming revealed that beyond the action of transcription factors, post-transcriptional regulation is also critical for cell fate determination. For example, they demonstrated that NAT1 (eIF4G2), a translation initiation factor, plays multiple roles in human stem cells depending on differentiation status. Their research addresses complex interactions between transcriptional control and post-transcriptional regulation, and contributes to innovative therapeutic options for patients including gene and cell therapies.

About Shinya

Professional Titles

  • Senior Investigator, Gladstone Institutes
  • L.K. Whittier Foundation Investigator in Stem Cell Biology, Gladstone Institutes
  • Professor, Department of Anatomy, UC San Francisco
  • Director Emeritus and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
  • President, CiRA Foundation

Bio

Shinya Yamanaka, MD, PhD, is a senior investigator and the L.K. Whittier Foundation Investigator in Stem Cell Biology at Gladstone Institutes. He is also a professor of anatomy at UC San Francisco (UCSF); Director Emeritus and professor of the Center for iPS Cell Research and Application (CiRA) at Kyoto University; and President of the CiRA Foundation in Japan.

Yamanaka earned an MD from Kobe University and a PhD from Osaka City University. From 1987 to 1989, he was a resident at the National Osaka Hospital. From 1993 to 1995, he was a postdoctoral fellow at Gladstone. Yamanaka then became an assistant professor at Osaka City University Medical School, and later an associate professor at Nara Institute of Science and Technology, where he eventually became a full professor in 2003. He took his current professor position at Kyoto University in 2004, and was appointed senior investigator at Gladstone Institutes in 2007. Since 2008, he has been directing CiRA.

In 2012, Yamanaka was awarded the Nobel Prize in Physiology or Medicine for his discovery that adult somatic cells can be reprogrammed into pluripotent cells. In addition, he has received many awards and honors, including the Albert Lasker Basic Medical Research Award, the Wolf Prize in Medicine, the Millennium Technology Award, the Shaw Prize, the Kyoto Prize for Advanced Technology, the Gairdner International Award, the Robert Koch Award, and the March of Dimes Prize.

Q:

How Did You Get Your Start in Science?

“As a young doctor, I saw many patients suffering from intractable diseases, including my own father. I want to overcome those diseases with science.”

Honors and Awards

  • 2026
    Honorary Degree, University of Bologna
  • 2025
    Distinguished Honorary Professor, Osaka Metropolitan University, Japan
  • 2023
    Taobuk Da Vinci Award, Italy
  • 2023
    Honorary Degree, University of Salamanca

Publications